Girish Dhall
University of Alabama at Birmingham · Children's Hospital of Alabama · Children's of Alabama at UAB
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Girish Dhall as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:18 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07743554 · Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath TumorGirish Dhall, MD · not yet recruiting · MPNST (Malignant Peripheral Nerve Sheath Tumor) · study director
- Ph2NCT07521657 · Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade GliomaUniversity of Alabama at Birmingham · not yet recruiting · Neurofibromatosis 1 (NF1) · study director
- Ph3NCT07291102 · Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk MedulloblastomaNationwide Children's Hospital · not yet recruiting · Medulloblastoma · study chair
- Ph1NCT06502171 · Study of Cabozantinib With Selumetinib for Plexiform NeurofibromasGirish Dhall, MD · recruiting · Neurofibromatosis 1, Plexiform Neurofibroma · study director
- Ph2NCT04283669 · Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular SchwannomasUniversity of Alabama at Birmingham · completed · Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS) · study director
- Ph4NCT02875314 · HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal TumorsParth Patel · active not recruiting · Medulloblastoma, Central Nervous System Embryonal Tumors · study chair
- Ph3NCT00392886 · Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain TumorsChildren's Hospital Los Angeles · unknown · Brain and Central Nervous System Tumors · unknown
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in medulloblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 12:18 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.Pediatr Blood Cancer · 2008173 citationsRCR 4.4
- 82 citationsRCR 2.5
- Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial.Neuro Oncol · 202081 citationsRCR 4.4
- Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience.Pediatr Blood Cancer · 20205 citationsRCR 0.4